M05.02

Clinical Causes: Most cases of Felty's syndrome occur in individuals with long-standing rheumatoid arthritis, suggesting a link between chronic autoimmune inflammation and the development of this syndrome. The exact cause remains unclear, but immune system dysregulation is believed to play a significant role. Genetic factors may predispose certain individuals to develop Felty's syndrome. Environmental triggers could contribute, although specific factors are not well established.

Key Symptoms: Swelling and pain in the elbow joint, often accompanied by warmth and tenderness. Splenomegaly, leading to an enlarged spleen that may cause a feeling of fullness or discomfort in the left upper abdomen. Neutropenia, resulting in a decreased number of neutrophils, which can lead to frequent infections. Fever and malaise due to immune system involvement. Fatigue and weakness. Recurrent or persistent infections, such as sore throats, skin infections, or pneumonia. Joint stiffness and swelling in other joints, often associated with rheumatoid arthritis.

Diagnosis Path: Diagnosis of Felty's syndrome involves a combination of clinical evaluation and laboratory tests. Key diagnostic steps include: - Medical history assessment, focusing on rheumatoid arthritis symptoms and disease duration. - Physical examination revealing an enlarged spleen and joint inflammation. - Blood tests showing low neutrophil counts and other blood cell abnormalities. - Imaging studies, such as ultrasound or MRI, to assess joint and spleen involvement. - Exclusion of other causes of neutropenia and splenomegaly. A definitive diagnosis hinges upon identifying the triad of rheumatoid arthritis, splenomegaly, and neutropenia.

Treatment Protocols: Managing Felty's syndrome involves addressing the underlying rheumatoid arthritis and controlling associated symptoms. Common treatment options include: - Disease-modifying antirheumatic drugs (DMARDs) to control rheumatoid arthritis and reduce immune system activity. - Corticosteroids to decrease inflammation and suppress immune response. - Antibiotics and growth factors like granulocyte colony-stimulating factor (G-CSF) to manage neutropenia and reduce infection risk. - Splenectomy (surgical removal of the spleen) in severe cases to improve neutropenia and decrease infection rates. - Regular monitoring of blood counts and spleen size. - Physical therapy to preserve joint function, especially in the elbow and other affected joints. Treatment plans are tailored to each individual's clinical condition, aiming to reduce symptoms and prevent complications.